Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 603 (LINC00603) is a human lincRNA longer than 200 nucleotides, transcribed from intergenic regions without encoding protein, and is annotated as NONHSAG040246.2 in genomic databases[3][5]. It belongs to the family of long non-coding RNAs, which are recognized for regulatory roles in gene expression, chromatin architecture, and modulation of nuclear processes, but the specific biological functions and disease links for LINC00603 are poorly characterized and unproven. Unlike other lincRNAs implicated in cancer or other diseases, LINC00603 has not been verified as a functional player or therapeutic target to date[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 603 (LINC00603).